| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diagnostic Imaging | 26 | 2022 | 1178 | 4.580 |
Why?
|
| Magnetic Resonance Imaging | 64 | 2023 | 7958 | 2.730 |
Why?
|
| Tomography, X-Ray Computed | 80 | 2023 | 7792 | 2.570 |
Why?
|
| Kidney Neoplasms | 20 | 2023 | 3153 | 2.060 |
Why?
|
| Neoplastic Syndromes, Hereditary | 4 | 2021 | 233 | 1.850 |
Why?
|
| Diagnosis, Differential | 35 | 2022 | 4900 | 1.440 |
Why?
|
| Adenoma, Liver Cell | 4 | 2022 | 16 | 1.410 |
Why?
|
| Gastrointestinal Neoplasms | 4 | 2022 | 624 | 1.290 |
Why?
|
| Pancreatic Diseases | 5 | 2016 | 113 | 1.270 |
Why?
|
| Pancreatic Neoplasms | 13 | 2021 | 5248 | 1.170 |
Why?
|
| Abdominal Neoplasms | 3 | 2020 | 249 | 1.160 |
Why?
|
| Autoimmune Diseases | 5 | 2016 | 433 | 0.960 |
Why?
|
| Multiple Organ Failure | 2 | 2016 | 177 | 0.940 |
Why?
|
| Urogenital Neoplasms | 3 | 2017 | 115 | 0.920 |
Why?
|
| Pelvic Neoplasms | 3 | 2016 | 203 | 0.910 |
Why?
|
| Urethral Diseases | 4 | 2015 | 39 | 0.890 |
Why?
|
| Solitary Fibrous Tumors | 3 | 2022 | 48 | 0.880 |
Why?
|
| Bile Duct Neoplasms | 4 | 2022 | 498 | 0.870 |
Why?
|
| Adrenal Gland Neoplasms | 3 | 2020 | 532 | 0.850 |
Why?
|
| Contrast Media | 26 | 2016 | 1510 | 0.840 |
Why?
|
| Sarcoidosis | 1 | 2023 | 116 | 0.830 |
Why?
|
| Sarcoma, Clear Cell | 2 | 2022 | 43 | 0.830 |
Why?
|
| Neuroectodermal Tumors | 1 | 2022 | 33 | 0.820 |
Why?
|
| Biliary Tract Diseases | 3 | 2016 | 64 | 0.800 |
Why?
|
| Hemangioma | 2 | 2022 | 161 | 0.800 |
Why?
|
| Cholangiocarcinoma | 5 | 2022 | 501 | 0.790 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 2 | 2021 | 143 | 0.790 |
Why?
|
| Liver Neoplasms | 13 | 2022 | 4811 | 0.780 |
Why?
|
| Image Enhancement | 8 | 2014 | 555 | 0.780 |
Why?
|
| Vascular Neoplasms | 1 | 2022 | 113 | 0.760 |
Why?
|
| Humans | 163 | 2023 | 272091 | 0.760 |
Why?
|
| Adenoma | 4 | 2023 | 745 | 0.750 |
Why?
|
| Seminoma | 1 | 2021 | 88 | 0.750 |
Why?
|
| Endometriosis | 1 | 2023 | 235 | 0.730 |
Why?
|
| Carcinoma, Renal Cell | 9 | 2015 | 2417 | 0.730 |
Why?
|
| Ultrasonography | 15 | 2019 | 1943 | 0.730 |
Why?
|
| Multimodal Imaging | 2 | 2014 | 553 | 0.710 |
Why?
|
| Ovarian Neoplasms | 7 | 2017 | 4797 | 0.700 |
Why?
|
| Granuloma, Plasma Cell | 3 | 2016 | 39 | 0.680 |
Why?
|
| Urinary Bladder | 1 | 2022 | 601 | 0.660 |
Why?
|
| Soft Tissue Neoplasms | 3 | 2022 | 918 | 0.660 |
Why?
|
| Genes, Neoplasm | 1 | 2020 | 317 | 0.650 |
Why?
|
| Testicular Neoplasms | 2 | 2021 | 555 | 0.650 |
Why?
|
| Urethra | 4 | 2015 | 168 | 0.630 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2021 | 343 | 0.620 |
Why?
|
| Obesity, Morbid | 3 | 2012 | 238 | 0.610 |
Why?
|
| Paraganglioma | 1 | 2020 | 199 | 0.590 |
Why?
|
| Pancreatitis | 4 | 2016 | 293 | 0.580 |
Why?
|
| Pheochromocytoma | 1 | 2020 | 313 | 0.560 |
Why?
|
| Hypercalcemia | 1 | 2017 | 145 | 0.550 |
Why?
|
| Myofibroma | 1 | 2016 | 12 | 0.540 |
Why?
|
| Prostate | 1 | 2022 | 1138 | 0.540 |
Why?
|
| Positron-Emission Tomography | 7 | 2016 | 2198 | 0.530 |
Why?
|
| Transplantation | 1 | 2015 | 56 | 0.520 |
Why?
|
| Duodenal Diseases | 2 | 2014 | 48 | 0.510 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2016 | 592 | 0.510 |
Why?
|
| Kidney | 8 | 2023 | 2267 | 0.500 |
Why?
|
| Testicular Diseases | 2 | 2012 | 22 | 0.500 |
Why?
|
| Immunoglobulin G | 2 | 2016 | 1140 | 0.500 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2016 | 84 | 0.490 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2016 | 155 | 0.490 |
Why?
|
| Carcinoma, Small Cell | 1 | 2017 | 427 | 0.490 |
Why?
|
| Neuroendocrine Tumors | 2 | 2020 | 653 | 0.480 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2020 | 1825 | 0.470 |
Why?
|
| Kidney Diseases, Cystic | 2 | 2012 | 66 | 0.460 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2016 | 522 | 0.460 |
Why?
|
| Abdomen | 5 | 2012 | 348 | 0.450 |
Why?
|
| Leiomyoma | 2 | 2012 | 160 | 0.430 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2015 | 382 | 0.430 |
Why?
|
| Multidetector Computed Tomography | 4 | 2016 | 148 | 0.420 |
Why?
|
| Scrotum | 2 | 2012 | 60 | 0.410 |
Why?
|
| Genomics | 2 | 2020 | 2830 | 0.410 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2022 | 2174 | 0.410 |
Why?
|
| Choriocarcinoma | 1 | 2012 | 49 | 0.400 |
Why?
|
| Postoperative Complications | 3 | 2015 | 5693 | 0.400 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2016 | 499 | 0.390 |
Why?
|
| Ovarian Diseases | 1 | 2012 | 51 | 0.390 |
Why?
|
| Genital Neoplasms, Male | 1 | 2011 | 45 | 0.390 |
Why?
|
| Gastric Bypass | 2 | 2010 | 92 | 0.390 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2019 | 564 | 0.380 |
Why?
|
| Evidence-Based Medicine | 5 | 2016 | 1060 | 0.380 |
Why?
|
| Pancreas | 5 | 2021 | 746 | 0.380 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2022 | 2446 | 0.370 |
Why?
|
| Chronic Disease | 1 | 2016 | 1855 | 0.360 |
Why?
|
| Esophageal Perforation | 2 | 2008 | 28 | 0.360 |
Why?
|
| Peritoneal Neoplasms | 2 | 2016 | 857 | 0.350 |
Why?
|
| Spinal Diseases | 3 | 2016 | 131 | 0.350 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2021 | 5756 | 0.350 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2012 | 299 | 0.330 |
Why?
|
| End Stage Liver Disease | 1 | 2011 | 186 | 0.330 |
Why?
|
| Taxoids | 2 | 2003 | 1010 | 0.330 |
Why?
|
| Female | 64 | 2023 | 149288 | 0.330 |
Why?
|
| Intestinal Obstruction | 2 | 2010 | 224 | 0.320 |
Why?
|
| Mesoderm | 1 | 2010 | 397 | 0.310 |
Why?
|
| Inflammation | 2 | 2016 | 2535 | 0.310 |
Why?
|
| Gadolinium DTPA | 3 | 2008 | 173 | 0.310 |
Why?
|
| Tomography, Spiral Computed | 3 | 2004 | 128 | 0.310 |
Why?
|
| Esophageal Diseases | 1 | 2008 | 79 | 0.300 |
Why?
|
| Ovary | 1 | 2012 | 701 | 0.300 |
Why?
|
| Biomarkers, Tumor | 5 | 2023 | 10750 | 0.300 |
Why?
|
| Kidney Diseases | 3 | 2011 | 732 | 0.300 |
Why?
|
| Male | 73 | 2023 | 129089 | 0.300 |
Why?
|
| Endocrine Gland Neoplasms | 1 | 2007 | 43 | 0.290 |
Why?
|
| Joint Diseases | 1 | 2008 | 71 | 0.290 |
Why?
|
| Epithelioid Cells | 1 | 2007 | 42 | 0.290 |
Why?
|
| Nephrons | 1 | 2007 | 47 | 0.290 |
Why?
|
| Deoxycytidine | 2 | 2003 | 1378 | 0.290 |
Why?
|
| Uterine Neoplasms | 1 | 2012 | 579 | 0.290 |
Why?
|
| Pelvis | 3 | 2022 | 384 | 0.290 |
Why?
|
| Digestive System Neoplasms | 1 | 2007 | 79 | 0.280 |
Why?
|
| Tuberculosis, Osteoarticular | 3 | 2001 | 9 | 0.280 |
Why?
|
| Rare Diseases | 4 | 2012 | 361 | 0.280 |
Why?
|
| Cysts | 2 | 2015 | 208 | 0.270 |
Why?
|
| Intestine, Small | 2 | 2010 | 527 | 0.270 |
Why?
|
| Adult | 49 | 2019 | 81933 | 0.270 |
Why?
|
| Laparoscopy | 3 | 2012 | 1298 | 0.270 |
Why?
|
| Practice Guidelines as Topic | 6 | 2019 | 2430 | 0.270 |
Why?
|
| Bariatric Surgery | 1 | 2008 | 124 | 0.260 |
Why?
|
| Parasitic Diseases | 1 | 2007 | 66 | 0.260 |
Why?
|
| Paclitaxel | 2 | 2003 | 2099 | 0.250 |
Why?
|
| Kidney Medulla | 1 | 2005 | 42 | 0.250 |
Why?
|
| Esophagus | 1 | 2008 | 564 | 0.250 |
Why?
|
| Bile Ducts, Intrahepatic | 2 | 2022 | 333 | 0.240 |
Why?
|
| Renal Insufficiency | 1 | 2008 | 318 | 0.240 |
Why?
|
| Hamartoma | 3 | 2000 | 120 | 0.240 |
Why?
|
| Skin Diseases | 1 | 2008 | 366 | 0.240 |
Why?
|
| Diverticulum | 2 | 2015 | 37 | 0.240 |
Why?
|
| Urethral Neoplasms | 2 | 2015 | 64 | 0.240 |
Why?
|
| Tumor Burden | 1 | 2010 | 2035 | 0.230 |
Why?
|
| Endometrial Neoplasms | 1 | 2013 | 1389 | 0.230 |
Why?
|
| beta Catenin | 2 | 2022 | 691 | 0.230 |
Why?
|
| Emergency Medical Services | 1 | 2008 | 465 | 0.220 |
Why?
|
| Malaria, Cerebral | 2 | 2002 | 5 | 0.220 |
Why?
|
| Adenomatoid Tumor | 1 | 2023 | 4 | 0.220 |
Why?
|
| Neoplasms, Mesothelial | 1 | 2023 | 7 | 0.220 |
Why?
|
| Lymphoma | 1 | 2012 | 1514 | 0.220 |
Why?
|
| Cystadenoma, Mucinous | 1 | 2003 | 35 | 0.220 |
Why?
|
| Liver Transplantation | 2 | 2011 | 1184 | 0.220 |
Why?
|
| Fatty Liver | 1 | 2005 | 257 | 0.210 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2013 | 1913 | 0.210 |
Why?
|
| Hemophilia A | 2 | 2001 | 28 | 0.210 |
Why?
|
| Enterocolitis, Neutropenic | 1 | 2022 | 19 | 0.200 |
Why?
|
| Radiology | 1 | 2008 | 428 | 0.200 |
Why?
|
| Brain Diseases | 3 | 2000 | 417 | 0.200 |
Why?
|
| Adenocarcinoma | 2 | 2020 | 7976 | 0.200 |
Why?
|
| Shock | 1 | 2023 | 96 | 0.200 |
Why?
|
| Critical Care | 1 | 2008 | 810 | 0.200 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2021 | 404 | 0.200 |
Why?
|
| von Hippel-Lindau Disease | 3 | 2012 | 123 | 0.200 |
Why?
|
| Seminal Vesicles | 1 | 2022 | 157 | 0.190 |
Why?
|
| Medical Oncology | 1 | 2010 | 1464 | 0.190 |
Why?
|
| Diagnostic Errors | 2 | 2016 | 532 | 0.190 |
Why?
|
| Fluoroscopy | 2 | 2014 | 225 | 0.180 |
Why?
|
| Biopsy | 5 | 2013 | 3544 | 0.180 |
Why?
|
| Peliosis Hepatis | 1 | 2000 | 2 | 0.180 |
Why?
|
| Clavicle | 1 | 2000 | 67 | 0.180 |
Why?
|
| Organ Transplantation | 1 | 2023 | 203 | 0.180 |
Why?
|
| Gastroplasty | 2 | 2012 | 21 | 0.180 |
Why?
|
| Whole Body Imaging | 2 | 2019 | 114 | 0.180 |
Why?
|
| Sarcoma, Kaposi | 1 | 2022 | 192 | 0.180 |
Why?
|
| Neurosurgical Procedures | 2 | 2016 | 646 | 0.180 |
Why?
|
| Multiple Myeloma | 1 | 2012 | 2287 | 0.180 |
Why?
|
| Radiopharmaceuticals | 3 | 2016 | 1338 | 0.180 |
Why?
|
| Fats | 1 | 1999 | 19 | 0.170 |
Why?
|
| Splenic Diseases | 1 | 2000 | 59 | 0.170 |
Why?
|
| Peritonitis, Tuberculous | 1 | 1999 | 11 | 0.170 |
Why?
|
| Chyle | 1 | 1999 | 22 | 0.170 |
Why?
|
| Sternum | 1 | 2000 | 96 | 0.170 |
Why?
|
| Glossopharyngeal Nerve Diseases | 1 | 1999 | 6 | 0.170 |
Why?
|
| Middle Aged | 34 | 2021 | 90460 | 0.170 |
Why?
|
| Trigeminal Nerve Diseases | 1 | 1999 | 14 | 0.170 |
Why?
|
| Radiography, Thoracic | 1 | 2002 | 474 | 0.170 |
Why?
|
| Chylous Ascites | 1 | 1999 | 25 | 0.170 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2022 | 370 | 0.170 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 441 | 0.170 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 1999 | 47 | 0.170 |
Why?
|
| Vascular Diseases | 2 | 2012 | 243 | 0.170 |
Why?
|
| Addison Disease | 1 | 1999 | 8 | 0.170 |
Why?
|
| Radiation Dosage | 3 | 2003 | 1043 | 0.170 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2016 | 1260 | 0.170 |
Why?
|
| Brain Diseases, Metabolic | 1 | 1999 | 17 | 0.160 |
Why?
|
| Leiomyosarcoma | 1 | 2021 | 255 | 0.160 |
Why?
|
| Neoplasm Staging | 6 | 2020 | 13993 | 0.160 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2023 | 879 | 0.160 |
Why?
|
| Mutation | 7 | 2022 | 15944 | 0.160 |
Why?
|
| Peritoneal Diseases | 1 | 1999 | 33 | 0.160 |
Why?
|
| Duodenum | 2 | 2022 | 170 | 0.160 |
Why?
|
| Neurilemmoma | 1 | 1999 | 134 | 0.160 |
Why?
|
| Syndrome | 2 | 2020 | 1407 | 0.160 |
Why?
|
| Linitis Plastica | 1 | 1998 | 12 | 0.160 |
Why?
|
| Hypothalamus | 1 | 2000 | 281 | 0.150 |
Why?
|
| Pleural Neoplasms | 1 | 2023 | 487 | 0.150 |
Why?
|
| Lung Neoplasms | 2 | 2016 | 12012 | 0.150 |
Why?
|
| Hematoma | 1 | 1999 | 159 | 0.150 |
Why?
|
| Mesothelioma | 1 | 2023 | 560 | 0.150 |
Why?
|
| Liver Diseases | 2 | 2014 | 605 | 0.150 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 3 | 2003 | 172 | 0.140 |
Why?
|
| Gastrointestinal Diseases | 1 | 2022 | 617 | 0.140 |
Why?
|
| Hemorrhage | 3 | 2023 | 747 | 0.140 |
Why?
|
| Carcinoid Tumor | 1 | 1998 | 282 | 0.140 |
Why?
|
| Radiography, Abdominal | 4 | 2008 | 124 | 0.130 |
Why?
|
| Sarcoma | 2 | 2021 | 1842 | 0.130 |
Why?
|
| Rupture, Spontaneous | 3 | 2008 | 69 | 0.130 |
Why?
|
| Abscess | 4 | 2001 | 192 | 0.130 |
Why?
|
| Choristoma | 2 | 2010 | 87 | 0.130 |
Why?
|
| Early Detection of Cancer | 3 | 2019 | 1342 | 0.130 |
Why?
|
| World Health Organization | 2 | 2010 | 328 | 0.130 |
Why?
|
| Bile Ducts | 1 | 2016 | 115 | 0.130 |
Why?
|
| Terminology as Topic | 2 | 2010 | 423 | 0.130 |
Why?
|
| Liver | 4 | 2014 | 3124 | 0.120 |
Why?
|
| Pancreatic Ducts | 1 | 2016 | 128 | 0.120 |
Why?
|
| Aged | 24 | 2021 | 73517 | 0.120 |
Why?
|
| Phenotype | 2 | 2020 | 6517 | 0.120 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2014 | 24 | 0.120 |
Why?
|
| Guidelines as Topic | 2 | 2010 | 371 | 0.120 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 107 | 0.120 |
Why?
|
| Epidural Abscess | 1 | 2014 | 13 | 0.120 |
Why?
|
| Aneurysm, False | 3 | 2001 | 143 | 0.120 |
Why?
|
| Melanoma | 1 | 2012 | 5592 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2016 | 755 | 0.120 |
Why?
|
| Hepatic Veins | 2 | 2012 | 59 | 0.120 |
Why?
|
| Radiography | 7 | 2012 | 1994 | 0.110 |
Why?
|
| Myxoma | 1 | 2014 | 68 | 0.110 |
Why?
|
| Colonoscopy | 1 | 2017 | 523 | 0.110 |
Why?
|
| Sensitivity and Specificity | 7 | 2014 | 5196 | 0.110 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2013 | 46 | 0.110 |
Why?
|
| Epithelium | 1 | 2016 | 805 | 0.110 |
Why?
|
| Neurosurgery | 1 | 2014 | 119 | 0.110 |
Why?
|
| Spinal Fusion | 1 | 2014 | 150 | 0.110 |
Why?
|
| Prognosis | 8 | 2021 | 22555 | 0.110 |
Why?
|
| Urinary Calculi | 1 | 2012 | 31 | 0.110 |
Why?
|
| Flank Pain | 1 | 2012 | 10 | 0.110 |
Why?
|
| Tuberous Sclerosis | 2 | 2012 | 144 | 0.100 |
Why?
|
| Neoplasms, Second Primary | 1 | 2021 | 1388 | 0.100 |
Why?
|
| Neoplasms | 4 | 2023 | 15930 | 0.100 |
Why?
|
| Tuberculosis, Female Genital | 1 | 2012 | 1 | 0.100 |
Why?
|
| Luteoma | 1 | 2012 | 1 | 0.100 |
Why?
|
| Oophoritis | 1 | 2012 | 3 | 0.100 |
Why?
|
| Young Adult | 5 | 2015 | 22142 | 0.100 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2012 | 14 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2011 | 16 | 0.100 |
Why?
|
| Pelvic Pain | 1 | 2012 | 47 | 0.100 |
Why?
|
| Angiomyolipoma | 2 | 2011 | 30 | 0.100 |
Why?
|
| Portal Vein | 2 | 2012 | 364 | 0.100 |
Why?
|
| Adolescent | 15 | 2015 | 32730 | 0.100 |
Why?
|
| Torsion Abnormality | 1 | 2012 | 38 | 0.100 |
Why?
|
| Pregnancy, Ectopic | 1 | 2012 | 38 | 0.100 |
Why?
|
| Female Urogenital Diseases | 1 | 2011 | 12 | 0.100 |
Why?
|
| Capecitabine | 2 | 2003 | 390 | 0.100 |
Why?
|
| Male Urogenital Diseases | 1 | 2011 | 19 | 0.100 |
Why?
|
| Acute Pain | 1 | 2012 | 49 | 0.100 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2015 | 443 | 0.100 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2011 | 108 | 0.100 |
Why?
|
| Fibroma | 1 | 2012 | 86 | 0.100 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2011 | 12 | 0.100 |
Why?
|
| Digestive System Diseases | 1 | 2011 | 39 | 0.100 |
Why?
|
| HIV Infections | 2 | 2022 | 2158 | 0.090 |
Why?
|
| Antineoplastic Agents | 4 | 2011 | 14653 | 0.090 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2012 | 73 | 0.090 |
Why?
|
| Medullary Sponge Kidney | 1 | 2010 | 4 | 0.090 |
Why?
|
| Tuberculosis, Spinal | 2 | 2001 | 12 | 0.090 |
Why?
|
| Mass Screening | 1 | 2019 | 1548 | 0.090 |
Why?
|
| Urinary Bladder Diseases | 1 | 2010 | 54 | 0.090 |
Why?
|
| Statistics as Topic | 2 | 2014 | 458 | 0.090 |
Why?
|
| Reproducibility of Results | 5 | 2014 | 6211 | 0.090 |
Why?
|
| Ultrasonography, Doppler | 2 | 2010 | 276 | 0.090 |
Why?
|
| Genital Diseases, Female | 1 | 2010 | 61 | 0.090 |
Why?
|
| Edema | 1 | 2012 | 265 | 0.090 |
Why?
|
| Prosthesis Implantation | 1 | 2012 | 244 | 0.090 |
Why?
|
| Radiography, Interventional | 1 | 2012 | 312 | 0.090 |
Why?
|
| Mullerian Ducts | 1 | 2010 | 79 | 0.090 |
Why?
|
| Europe | 1 | 2011 | 660 | 0.090 |
Why?
|
| Endocrine System Diseases | 1 | 2010 | 91 | 0.090 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2010 | 84 | 0.090 |
Why?
|
| Body Weight | 3 | 2003 | 1335 | 0.090 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2012 | 235 | 0.090 |
Why?
|
| Rectal Neoplasms | 1 | 1998 | 1240 | 0.080 |
Why?
|
| Angiography | 4 | 2004 | 353 | 0.080 |
Why?
|
| Echinococcosis | 2 | 1999 | 14 | 0.080 |
Why?
|
| Cervix Uteri | 1 | 2010 | 252 | 0.080 |
Why?
|
| Cytogenetic Analysis | 1 | 2011 | 574 | 0.080 |
Why?
|
| Spinal Cord | 3 | 2001 | 724 | 0.080 |
Why?
|
| Biliary Fistula | 2 | 1999 | 10 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 338 | 0.080 |
Why?
|
| Risk Factors | 4 | 2015 | 18051 | 0.080 |
Why?
|
| Aged, 80 and over | 11 | 2014 | 31066 | 0.080 |
Why?
|
| Actinomyces | 1 | 2008 | 5 | 0.080 |
Why?
|
| Breast Neoplasms | 2 | 2003 | 16244 | 0.080 |
Why?
|
| Fluorouracil | 2 | 2003 | 1988 | 0.080 |
Why?
|
| Jejunoileal Bypass | 1 | 2008 | 6 | 0.080 |
Why?
|
| Biliopancreatic Diversion | 1 | 2008 | 5 | 0.080 |
Why?
|
| Connective Tissue Diseases | 1 | 2008 | 48 | 0.080 |
Why?
|
| Actinomycosis | 1 | 2008 | 8 | 0.080 |
Why?
|
| Adenofibroma | 1 | 2008 | 20 | 0.080 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2008 | 24 | 0.080 |
Why?
|
| Ileus | 1 | 2008 | 30 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2012 | 917 | 0.070 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2008 | 83 | 0.070 |
Why?
|
| Gastroenteritis | 1 | 2010 | 353 | 0.070 |
Why?
|
| Hernia, Abdominal | 1 | 2008 | 41 | 0.070 |
Why?
|
| Preoperative Care | 2 | 2004 | 1553 | 0.070 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2000 | 277 | 0.070 |
Why?
|
| Kidney Tubules | 1 | 2007 | 146 | 0.070 |
Why?
|
| Embolization, Therapeutic | 3 | 2001 | 606 | 0.070 |
Why?
|
| Kidney Glomerulus | 1 | 2007 | 177 | 0.070 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2011 | 630 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 1 | 2008 | 265 | 0.070 |
Why?
|
| Tropical Medicine | 1 | 2007 | 104 | 0.060 |
Why?
|
| Disease Progression | 2 | 2010 | 6911 | 0.060 |
Why?
|
| Abdominal Wall | 1 | 2008 | 192 | 0.060 |
Why?
|
| Patient Selection | 1 | 2012 | 2045 | 0.060 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2012 | 1011 | 0.060 |
Why?
|
| Fibrosis | 1 | 2008 | 747 | 0.060 |
Why?
|
| Hematuria | 1 | 2005 | 86 | 0.060 |
Why?
|
| Gastroesophageal Reflux | 1 | 2008 | 366 | 0.060 |
Why?
|
| Occipital Bone | 2 | 2001 | 30 | 0.060 |
Why?
|
| Child | 14 | 2019 | 30559 | 0.060 |
Why?
|
| Surgical Wound Infection | 1 | 2008 | 481 | 0.060 |
Why?
|
| Body Weights and Measures | 1 | 2003 | 53 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2011 | 4513 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 10365 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2004 | 219 | 0.060 |
Why?
|
| Thorium Dioxide | 1 | 2003 | 2 | 0.050 |
Why?
|
| Genotype | 1 | 2011 | 4267 | 0.050 |
Why?
|
| Follow-Up Studies | 6 | 2023 | 15279 | 0.050 |
Why?
|
| Ependymoma | 1 | 2005 | 269 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2010 | 962 | 0.050 |
Why?
|
| Liver Circulation | 1 | 2002 | 36 | 0.050 |
Why?
|
| Consciousness | 1 | 2002 | 55 | 0.050 |
Why?
|
| Pyridoxal Phosphate | 1 | 2002 | 16 | 0.050 |
Why?
|
| Child, Preschool | 10 | 2011 | 17056 | 0.050 |
Why?
|
| Brain Edema | 1 | 2002 | 96 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2010 | 1699 | 0.050 |
Why?
|
| Edetic Acid | 1 | 2002 | 76 | 0.050 |
Why?
|
| Cysticercosis | 1 | 2001 | 31 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2003 | 331 | 0.050 |
Why?
|
| Arachnoiditis | 1 | 2001 | 2 | 0.050 |
Why?
|
| Mammary Arteries | 1 | 2001 | 47 | 0.050 |
Why?
|
| Myelography | 1 | 2001 | 21 | 0.050 |
Why?
|
| Pancreatic Cyst | 1 | 2002 | 114 | 0.050 |
Why?
|
| Arachnoid Cysts | 1 | 2001 | 13 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2012 | 9046 | 0.050 |
Why?
|
| Axis, Cervical Vertebra | 1 | 2001 | 6 | 0.050 |
Why?
|
| Tuberculosis | 3 | 2010 | 614 | 0.050 |
Why?
|
| Catheterization | 2 | 2002 | 425 | 0.050 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2002 | 87 | 0.050 |
Why?
|
| Cervical Atlas | 1 | 2001 | 22 | 0.050 |
Why?
|
| Ribs | 1 | 2001 | 85 | 0.050 |
Why?
|
| Algorithms | 2 | 2010 | 3925 | 0.050 |
Why?
|
| Radiologists | 1 | 2023 | 178 | 0.050 |
Why?
|
| Spinal Cord Diseases | 1 | 2001 | 90 | 0.050 |
Why?
|
| Synovitis, Pigmented Villonodular | 1 | 2000 | 16 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2015 | 33909 | 0.050 |
Why?
|
| Plasma Cell Granuloma, Pulmonary | 1 | 2000 | 6 | 0.050 |
Why?
|
| Brain | 4 | 2002 | 4260 | 0.050 |
Why?
|
| Mandibular Diseases | 1 | 2001 | 49 | 0.050 |
Why?
|
| Hip Joint | 1 | 2000 | 58 | 0.050 |
Why?
|
| Sarcoma, Synovial | 2 | 2012 | 130 | 0.050 |
Why?
|
| Tuberculosis, Hepatic | 1 | 2000 | 4 | 0.050 |
Why?
|
| Drainage | 2 | 2001 | 448 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 4968 | 0.040 |
Why?
|
| Mucins | 1 | 2021 | 289 | 0.040 |
Why?
|
| Choroid Plexus Neoplasms | 1 | 2000 | 32 | 0.040 |
Why?
|
| Orbital Pseudotumor | 1 | 2000 | 15 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2002 | 16612 | 0.040 |
Why?
|
| Liver Abscess | 1 | 2000 | 37 | 0.040 |
Why?
|
| Pregnancy | 2 | 2012 | 8105 | 0.040 |
Why?
|
| Methanol | 1 | 1999 | 19 | 0.040 |
Why?
|
| Synovial Cyst | 1 | 1999 | 7 | 0.040 |
Why?
|
| Jugular Veins | 1 | 2000 | 113 | 0.040 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2000 | 23 | 0.040 |
Why?
|
| Rabies Vaccines | 1 | 1999 | 12 | 0.040 |
Why?
|
| Central Nervous System Parasitic Infections | 1 | 1999 | 2 | 0.040 |
Why?
|
| Hemoptysis | 1 | 2000 | 41 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 3856 | 0.040 |
Why?
|
| Tuberculosis, Gastrointestinal | 1 | 1999 | 13 | 0.040 |
Why?
|
| Median Eminence | 1 | 1999 | 10 | 0.040 |
Why?
|
| Aneurysm, Ruptured | 1 | 2000 | 44 | 0.040 |
Why?
|
| Ileal Neoplasms | 1 | 1999 | 49 | 0.040 |
Why?
|
| Ileal Diseases | 1 | 1999 | 28 | 0.040 |
Why?
|
| Retrospective Studies | 8 | 2015 | 39831 | 0.040 |
Why?
|
| Sacrum | 1 | 2000 | 139 | 0.040 |
Why?
|
| Incidence | 1 | 2010 | 5864 | 0.040 |
Why?
|
| Tuberculosis, Endocrine | 1 | 1999 | 2 | 0.040 |
Why?
|
| Splenectomy | 1 | 2000 | 168 | 0.040 |
Why?
|
| Goiter, Nodular | 1 | 1999 | 6 | 0.040 |
Why?
|
| Hypopituitarism | 1 | 1999 | 29 | 0.040 |
Why?
|
| Myelitis | 1 | 1999 | 24 | 0.040 |
Why?
|
| Thyroiditis | 1 | 1999 | 19 | 0.040 |
Why?
|
| Liver Abscess, Amebic | 1 | 1999 | 3 | 0.040 |
Why?
|
| Arteriovenous Fistula | 1 | 2000 | 104 | 0.040 |
Why?
|
| Pulmonary Embolism | 1 | 2003 | 343 | 0.040 |
Why?
|
| Intussusception | 1 | 1999 | 53 | 0.040 |
Why?
|
| Lipoma | 1 | 1999 | 94 | 0.040 |
Why?
|
| Mediastinal Diseases | 1 | 1999 | 59 | 0.040 |
Why?
|
| Echinococcosis, Hepatic | 1 | 1998 | 8 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2000 | 249 | 0.040 |
Why?
|
| Pituitary Gland | 1 | 1999 | 157 | 0.040 |
Why?
|
| Neuroectodermal Tumor, Melanotic | 1 | 1998 | 1 | 0.040 |
Why?
|
| Fibromatosis, Aggressive | 1 | 2000 | 110 | 0.040 |
Why?
|
| Bronchial Fistula | 1 | 1999 | 37 | 0.040 |
Why?
|
| Hypothalamic Diseases | 1 | 1999 | 66 | 0.040 |
Why?
|
| Intestinal Fistula | 1 | 1998 | 47 | 0.040 |
Why?
|
| Optic Nerve Diseases | 1 | 2000 | 111 | 0.040 |
Why?
|
| Skull | 1 | 2000 | 252 | 0.040 |
Why?
|
| Omentum | 1 | 1999 | 107 | 0.040 |
Why?
|
| Thymus Gland | 1 | 1999 | 312 | 0.040 |
Why?
|
| Angiomatosis | 1 | 1998 | 27 | 0.040 |
Why?
|
| Jejunal Diseases | 1 | 1998 | 26 | 0.040 |
Why?
|
| Family Health | 1 | 2019 | 348 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2006 | 1324 | 0.040 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 1999 | 129 | 0.040 |
Why?
|
| Spleen | 1 | 2000 | 732 | 0.040 |
Why?
|
| Anemia, Aplastic | 1 | 1999 | 233 | 0.040 |
Why?
|
| United States | 2 | 2011 | 16066 | 0.040 |
Why?
|
| Carcinoma | 1 | 2008 | 2623 | 0.030 |
Why?
|
| Observer Variation | 3 | 2003 | 721 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2019 | 417 | 0.030 |
Why?
|
| Teratoma | 1 | 1999 | 253 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2023 | 1443 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2015 | 2681 | 0.030 |
Why?
|
| Fetus | 1 | 2000 | 674 | 0.030 |
Why?
|
| Nose Neoplasms | 1 | 1998 | 236 | 0.030 |
Why?
|
| Staphylococcal Infections | 1 | 2001 | 682 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2000 | 521 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2020 | 1827 | 0.030 |
Why?
|
| Breast Diseases | 1 | 1997 | 206 | 0.030 |
Why?
|
| Braces | 1 | 2014 | 14 | 0.030 |
Why?
|
| Arthrodesis | 1 | 2014 | 15 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2005 | 2975 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1999 | 501 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1999 | 489 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2014 | 126 | 0.030 |
Why?
|
| Low Back Pain | 1 | 2014 | 83 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2014 | 250 | 0.030 |
Why?
|
| Angiolipoma | 1 | 2012 | 3 | 0.030 |
Why?
|
| Mammography | 1 | 2019 | 1047 | 0.030 |
Why?
|
| Lymphangioma | 1 | 2012 | 35 | 0.030 |
Why?
|
| Urography | 1 | 2012 | 58 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 4400 | 0.020 |
Why?
|
| Cystoscopy | 1 | 2012 | 92 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1999 | 850 | 0.020 |
Why?
|
| Renal Artery | 1 | 2011 | 89 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2012 | 257 | 0.020 |
Why?
|
| Cytogenetics | 1 | 2011 | 152 | 0.020 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2011 | 49 | 0.020 |
Why?
|
| Arteriovenous Malformations | 1 | 2011 | 68 | 0.020 |
Why?
|
| Aneurysm | 1 | 2011 | 91 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 2 | 2004 | 410 | 0.020 |
Why?
|
| Vasculitis | 1 | 2011 | 78 | 0.020 |
Why?
|
| Statistics, Nonparametric | 2 | 2003 | 996 | 0.020 |
Why?
|
| Fibrosarcoma | 1 | 2011 | 142 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2012 | 263 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2011 | 197 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2011 | 181 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2011 | 324 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 2337 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2011 | 196 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 522 | 0.020 |
Why?
|
| Celiac Disease | 1 | 2010 | 80 | 0.020 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2010 | 75 | 0.020 |
Why?
|
| Niacinamide | 1 | 2011 | 427 | 0.020 |
Why?
|
| Glioma | 1 | 2000 | 1988 | 0.020 |
Why?
|
| Genes, ras | 1 | 2012 | 681 | 0.020 |
Why?
|
| Chondrosarcoma | 1 | 2011 | 213 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2010 | 140 | 0.020 |
Why?
|
| Liposarcoma | 1 | 2011 | 248 | 0.020 |
Why?
|
| Hemangiosarcoma | 1 | 2011 | 238 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1999 | 1737 | 0.020 |
Why?
|
| Rhabdomyosarcoma | 1 | 2011 | 343 | 0.020 |
Why?
|
| Fatal Outcome | 2 | 2000 | 835 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 2011 | 381 | 0.020 |
Why?
|
| Colitis | 1 | 2010 | 344 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2011 | 600 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2014 | 2290 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2010 | 334 | 0.020 |
Why?
|
| Transducers | 1 | 2007 | 59 | 0.020 |
Why?
|
| Sarcoma, Ewing | 1 | 2011 | 426 | 0.020 |
Why?
|
| Calcinosis | 1 | 2010 | 432 | 0.020 |
Why?
|
| Anisotropy | 1 | 2007 | 186 | 0.020 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2007 | 64 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 1095 | 0.020 |
Why?
|
| Brain Neoplasms | 2 | 2005 | 4994 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2007 | 327 | 0.020 |
Why?
|
| Neurofibromin 2 | 1 | 2005 | 41 | 0.020 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2004 | 65 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2004 | 176 | 0.010 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2005 | 159 | 0.010 |
Why?
|
| Blood Proteins | 1 | 2005 | 301 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2003 | 13410 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 4071 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 2011 | 948 | 0.010 |
Why?
|
| Pyridines | 1 | 2011 | 1312 | 0.010 |
Why?
|
| Living Donors | 1 | 2004 | 178 | 0.010 |
Why?
|
| Vagina | 1 | 2006 | 331 | 0.010 |
Why?
|
| Gadolinium | 1 | 2004 | 172 | 0.010 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2004 | 127 | 0.010 |
Why?
|
| Equipment Design | 1 | 2007 | 1207 | 0.010 |
Why?
|
| Hepatic Artery | 1 | 2004 | 257 | 0.010 |
Why?
|
| Incidental Findings | 1 | 2005 | 282 | 0.010 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2002 | 27 | 0.010 |
Why?
|
| Cystadenocarcinoma, Mucinous | 1 | 2002 | 22 | 0.010 |
Why?
|
| Cystadenoma, Serous | 1 | 2002 | 31 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 544 | 0.010 |
Why?
|
| Papilloma, Intraductal | 1 | 2002 | 17 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 1998 | 3704 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2005 | 533 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2005 | 498 | 0.010 |
Why?
|
| Prevalence | 1 | 2010 | 3427 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2005 | 9500 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 2 | 2008 | 3176 | 0.010 |
Why?
|
| Infant | 3 | 2005 | 13970 | 0.010 |
Why?
|
| Manganese | 1 | 2002 | 65 | 0.010 |
Why?
|
| Iophendylate | 1 | 2001 | 1 | 0.010 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2003 | 173 | 0.010 |
Why?
|
| Tissue Adhesions | 1 | 2001 | 52 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 2001 | 57 | 0.010 |
Why?
|
| Parietal Bone | 1 | 2000 | 19 | 0.010 |
Why?
|
| Frontal Bone | 1 | 2000 | 28 | 0.010 |
Why?
|
| Wounds, Stab | 1 | 2000 | 41 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 13139 | 0.010 |
Why?
|
| Thorax | 1 | 2001 | 231 | 0.010 |
Why?
|
| Neck Injuries | 1 | 2000 | 37 | 0.010 |
Why?
|
| Poisoning | 1 | 1999 | 22 | 0.010 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2003 | 379 | 0.010 |
Why?
|
| Retroperitoneal Space | 1 | 2000 | 156 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2005 | 2319 | 0.010 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 1999 | 27 | 0.010 |
Why?
|
| Spinal Cord Compression | 1 | 2001 | 168 | 0.010 |
Why?
|
| Paresis | 1 | 1999 | 55 | 0.010 |
Why?
|
| Facial Paralysis | 1 | 1999 | 58 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1999 | 268 | 0.010 |
Why?
|
| Swine | 1 | 2003 | 1610 | 0.010 |
Why?
|
| Neck | 1 | 2001 | 386 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1998 | 47 | 0.010 |
Why?
|
| Aortography | 1 | 1999 | 173 | 0.010 |
Why?
|
| Steroids | 1 | 2000 | 375 | 0.010 |
Why?
|
| Vision Disorders | 1 | 2000 | 241 | 0.010 |
Why?
|
| Hepatectomy | 1 | 2004 | 1013 | 0.010 |
Why?
|
| Hydrocephalus | 1 | 2000 | 260 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 1707 | 0.010 |
Why?
|
| Nasal Cavity | 1 | 1998 | 146 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 1905 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2003 | 2355 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2000 | 460 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2004 | 2157 | 0.010 |
Why?
|
| Antitubercular Agents | 1 | 1999 | 350 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2012 | 5603 | 0.010 |
Why?
|
| Animals | 2 | 2016 | 62827 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2002 | 1237 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1997 | 581 | 0.010 |
Why?
|
| Down Syndrome | 1 | 1998 | 227 | 0.010 |
Why?
|
| Pneumonectomy | 1 | 2000 | 862 | 0.010 |
Why?
|
| Acute Disease | 1 | 1999 | 2517 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 7828 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 7476 | 0.010 |
Why?
|
| Lung | 1 | 2000 | 3295 | 0.000 |
Why?
|